| Company Name | Bayer Taiwan Co., Ltd. |
|---|---|
| Protocol Number | 18559 |
| Title of Study | TAURUS: A MulTinational PhAse IV Study EvalUating “Real World” Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog alfa) for RoUtine ProphylaxiS. |
| Primary Objective | The primary objective of this study is to investigate weekly prophylaxis dosing regimens used in standard clinical practice. |
| Number of Sites | 5 |
| Period of Study | From：Jun 2018 to：Jan 2020 |
| Number of Patients | 24人 |
| IRB Approval Date | Taipei Veterans General Hospital: 24May2018 Taichung Veterans General Hospital: 5Jun2018 Kaohsiung Medical University Chung-Ho Memorial Hospital: 8Jun2018 China Medical University Hospital: 26May2018 Pingtung Christian Hospital : 4Jul2018 |
| Publication Plan / Date | 2020 |
